Mankind Pharma Limited has informed the Exchange about Schedule of meet
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mankind Pharma has informed the stock exchanges about an investor conference call scheduled for Friday, August 1, 2025, at 12:00 noon IST. The call will cover the company's Q1 FY26 business performance and financial results. Senior management will participate, including Vice Chairman & MD Rajeev Juneja, CEO Sheetal Arora, COO Arjun Juneja, Global CFO Ashutosh Dhawan, and the Head of Investor Relations. Dial-in details for domestic and international participants have been shared, and the invite is also available on the company's website.
This is a routine calendar announcement with no direct impact on the stock price. Investors should watch the Q1 FY26 earnings call on August 1 for actual performance numbers and management commentary, which could drive near-term sentiment.